.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Mallinckrodt
Moodys
Merck
McKinsey
Daiichi Sankyo
Citi
Healthtrust
Cipla
Harvard Business School

Generated: July 21, 2017

DrugPatentWatch Database Preview

Betamethasone dipropionate; clotrimazole - Generic Drug Details

« Back to Dashboard

What are the generic sources for betamethasone dipropionate; clotrimazole and what is the scope of betamethasone dipropionate; clotrimazole patent protection?

Betamethasone dipropionate; clotrimazole
is the generic ingredient in two branded drugs marketed by Actavis Mid Atlantic, Fougera Pharms, Merck Sharp Dohme, Taro, and Glenmark Pharms, and is included in eight NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are sixty-six drug master file entries for betamethasone dipropionate; clotrimazole. Sixteen suppliers are listed for this compound.

Summary for Generic Name: betamethasone dipropionate; clotrimazole

Tradenames:2
Patents:1
Applicants:5
NDAs:8
Drug Master File Entries: see list66
Suppliers / Packagers: see list16
Clinical Trials: see list219
Drug Prices:see low prices
DailyMed Link:betamethasone dipropionate; clotrimazole at DailyMed

Pharmacology for Ingredient: betamethasone dipropionate; clotrimazole

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms
CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
betamethasone dipropionate; clotrimazole
CREAM;TOPICAL075502-001Jun 5, 2001ABRXNoNo► Subscribe► Subscribe
Glenmark Pharms
CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
betamethasone dipropionate; clotrimazole
CREAM;TOPICAL202894-001Oct 30, 2015ABRXNoNo► Subscribe► Subscribe
Taro
CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
betamethasone dipropionate; clotrimazole
CREAM;TOPICAL075673-001May 29, 2001ABRXNoNo► Subscribe► Subscribe
Actavis Mid Atlantic
CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
betamethasone dipropionate; clotrimazole
CREAM;TOPICAL076002-001Aug 2, 2002ABRXNoNo► Subscribe► Subscribe
Taro
CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
betamethasone dipropionate; clotrimazole
LOTION;TOPICAL076493-001Jul 28, 2004ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: betamethasone dipropionate; clotrimazole

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck Sharp Dohme
LOTRISONE
betamethasone dipropionate; clotrimazole
CREAM;TOPICAL018827-001Jul 10, 19843,660,577► Subscribe
Merck Sharp Dohme
LOTRISONE
betamethasone dipropionate; clotrimazole
CREAM;TOPICAL018827-001Jul 10, 19843,839,573► Subscribe
Merck Sharp Dohme
LOTRISONE
betamethasone dipropionate; clotrimazole
CREAM;TOPICAL018827-001Jul 10, 19844,298,604► Subscribe
Merck Sharp Dohme
LOTRISONE
betamethasone dipropionate; clotrimazole
CREAM;TOPICAL018827-001Jul 10, 19843,705,172► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Accenture
Johnson and Johnson
Queensland Health
US Army
Chinese Patent Office
Healthtrust
Covington
Mallinckrodt
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot